List your tool

Head to head · 2026

AI Optics vs NeuroClues

Pricing, free plans, ratings, features, pros and cons, side by side. Where one comes out ahead, we mark it.

AI Optics

Portable, FDA-cleared retinal camera pairing proprietary optics with on-device AI screening

4.0Not listed

Visit AI Optics (opens AI Optics in a new tab)

NeuroClues

Eye-tracking medical device that uses AI to detect early biomarkers of Parkinson's, Alzheimer's, and multiple sclerosis

4.3Not listed

Visit NeuroClues (opens NeuroClues in a new tab)

Who comes out ahead

Based only on the facts in our directory. The right pick still depends on the job you need done.

  • Lower starting price

    Not comparable

    Not comparable: AI Optics does not list a price

  • Free plan

    Tie

    Neither has one

  • Higher rating

    NeuroClues

    4.0 against 4.3

  • Same job?

    Yes

    Both are Healthcare AI tools

Side by side

Compared onAI OpticsNeuroClues
Our rating4.04.3Better
Starts atNot listedNot listed
Free planNoNo
CategoryHealthcare AIHealthcare AI
PlansSee pricingSee pricing
Key features
  • Handheld, rechargeable fundus camera
  • On-device AI screening for diabetic retinopathy, AMD, and glaucoma
  • No pupil dilation required for imaging
  • FDA 510(k)-cleared hardware
  • Sub-two-minute screening workflow for medical assistants
  • Portable, CE-marked Class IIa medical device for clinical eye-movement recording
  • Calibration-free patient setup using dual infrared cameras at 400 fps
  • AI-derived biomarkers benchmarked against reference ranges for clinical interpretation
  • Early-detection targeting for Parkinson's, Alzheimer's, and multiple sclerosis
  • Deployment across university hospitals and private neurology practices in seven-plus countries
Pros
  • FDA clearance backs the device for clinical use
  • Portable design suits primary care and retail health settings
  • Screens for three retinal conditions from one capture
  • CE-marked Class IIa medical device status gives it real regulatory clearance, not only research-stage promise
  • More than €22 million raised, including a €10 million Series A, signals investor confidence
  • Aims at detection years before visible symptoms, where neurological treatment has the most impact
Cons
  • Requires purchasing dedicated hardware, not software-only
  • Pricing isn't published; requires a sales conversation
  • Screening covers retinal disease only, not general eye exams
  • No published pricing, and as a clinical device it is sold directly to institutions, not individuals
  • Limited so far to the European market and CE marking, without confirmed FDA clearance
  • As a diagnostic aid, findings still require a neurologist's clinical interpretation, not a standalone verdict
CompanyAI Optics, founded 2020neuroClues, founded 2020

Prices come from each vendor's pricing page, last checked 20260801. Check the vendor before you buy.

FAQ

Questions people ask

Is AI Optics better than NeuroClues?

In our reviews AI Optics scores 4.0 and NeuroClues scores 4.3. The better pick depends on the job. AI Optics: Portable, FDA-cleared retinal camera pairing proprietary optics with on-device AI screening. NeuroClues: Eye-tracking medical device that uses AI to detect early biomarkers of Parkinson's, Alzheimer's, and multiple sclerosis.

Which is cheaper, AI Optics or NeuroClues?

AI Optics: see pricing. NeuroClues: see pricing.

Do AI Optics and NeuroClues have free plans?

Neither lists a free plan.

More comparisons